EXPRESS-Pick Collection Screening Compound Stock
ChemBridge CorporationThe EXPRESS-Pick small molecule screening compound stock is a collection of 460,000 druglike, small molecule compounds, available for custom selection.
Identification and optimization of the chemical, series of chemicals or bio-molecule that will interact with the target using impartial, expert opinion about the best equipment, services and the latest techniques
The EXPRESS-Pick small molecule screening compound stock is a collection of 460,000 druglike, small molecule compounds, available for custom selection.
Structurally diverse small molecule libraries with broad 3D pharmacophore coverage for hit identification ChemBridge offers two, complementary DIVERSet™ Libraries, each composed of 50,000 leadlike and druglike compounds. Both DIVERSet Libraries (the DIVERSet-EXP and the DIVERSet-CL) are designed to provide the greatest coverage of pharmacophore space within 50,000 compounds while maintaining chemical structure diversity. Th…
CNS-directed selection from ChemBridge's EXPRESS-Pick Collection screening compound stock.
Pre-plated selection from ChemBridge's EXPRESS-Pick Collection screening compound stock.
Ion channel-directed selection from ChemBridge's EXPRESS-Pick Collection screening compound stock.
GPCR-targeted compounds based on beta-turn mimetic scaffolds designed by ChemBridge.
Kinase-directed selection from ChemBridge's EXPRESS-Pick Collection screening compound stock.
Kinase-directed selection from ChemBridge's CORE Library screening compound stock.
Roche NimbleGen provides a unique combination of high-density arrays, long-oligo probes, and flexible design capability that together provide superior results for advanced gene expression analysis. NimbleGen microarrays enable accurate, sensitive, and specific interrogation of genome-wide expression for any sequenced and annotated genome. Researchers also can tile through a genome at any desired spacing to discover genome-wide…
Agilent’s contract Lead Discovery Service utilizes label-free RapidFire technology for direct quantitation of a wide range of native analytes across diverse therapeutic areas. Supports SAR programs via retesting of hits. Uses your existing assays or RapidFire custom-developed assays. Quick data turnaround for faster drug discovery decisions.Screened as singletons or compressed format The ideal candidate assays are often the sa…